* FDA clears Biohaven’s investigational new drug application
for BHV 4157 and portage to hold investor conference call to
provide business update
Source text for Eikon:
Further company coverage:
…
The post BRIEF-FDA clears Biohaven’s investigational new drug application for BHV-4157 appeared first on NASDAQ.